Procurement Summary
Country: Argentina
Summary: Acquisition - Medications Annex Ii - Deserts and Failures
Deadline: 04 May 2026
Posting Date: 02 May 2026
Other Information
Notice Type: Tender
TOT Ref.No.: 140560641
Document Ref. No.: 401-0405-CDI26
Competition: NCB
Financier: Self Financed
Purchaser Ownership: Public
Tender Value: ARS 520543047.00
Purchaser's Detail
Name: Login to see tender_details
Address: Login to see tender_details
Email: Login to see tender_detailsLogin to see details
Tender Details
DINOPROSTONE. Model: 10 mg, vaginal release system, FOSFOMICINA SODIA. Model: 1, 000 mg, injectable, in vial, intravenous use, HUMAN FIBRINOGEN. Model: 1000 mg, injectable, lyophilized, in vial + solvent, with disposable infusion set, TIROFIBAN. Model: 0.25 mg/ml (As Hydrochloride Monohydrate), injectable, in vial bottle x 50 ml, PHYSIOLOGICAL HEMOSTATIC ADHESIVE. Model: Fibrinogen and factor XIII protein sealant, aprotinin solution, Lyophilized thrombin and calcium solution, chloride, in kit x 3 ml, SPIRAMYCIN. Model: 1000 mg, tablet
File number: EX-2026-18053835- -GCABA-DGACSA Legal framework: Law N? 2, 095 (Consolidated Text by Law No. 6, 588) and Decree No. 129/23 Art. 29 Other conditions: Requires technical advice Responsible area: Technical Support Operational Deputy Manager More info: Place of receipt of physical documentation: Rivadavia 524, 4th floor, DGACSA Office
Documents
Tender Notice